Compare
Johnson & Johnson vs Zoetis (JNJ vs ZTS)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Johnson & Johnson (JNJ) returned +48.5% and Zoetis (ZTS) -34.1%; so far this year the figures are +33.5% and -36.9%.
Johnson & Johnson is the larger company by market value, about 20.6 times the size of Zoetis.
On trailing earnings, JNJ trades at 41.9 times and ZTS at 13.4 times.
Revenue grew +7.8% at JNJ and +0.9% at ZTS over the last year.
JNJ yields 1.91%. ZTS yields 2.67%.
Data as of the latest close. Not investment advice.
Relative performance
| JNJ | ZTS | |
|---|---|---|
| Price | $276.22 | $79.40 |
| 1-day | +1.43% | -3.30% |
| YTD | +33.47% | -36.89% |
| 1 year | +48.51% | -34.10% |
| 3 years | +85.77% | -47.57% |
| Market cap | $665.0B | $32.3B |
| P/E | 41.9 | 13.4 |
| P/S | 6.69 | 3.40 |
| P/B | 8.16 | 9.77 |
| Revenue growth | +7.80% | +0.90% |
| EPS growth | -36.40% | +0.70% |
| Gross margin % | 67.6 | 71.6 |
| Net margin % | 16.2 | 26.4 |
| ROE % | 19.7 | 75.9 |
| Debt / equity | 0.55 | 2.74 |
| FCF yield % | 3.1 | 6.9 |
| Dividend yield % | 1.91 | 2.67 |
| Beta | -0.09 | 0.59 |
| RSI (14) | 59.4 | 51.1 |
| Technical rating |